The myth of sickle cell trait

Area of Science:

• Hematology
• Medical Genetics
• Public Health

Background:

• Recent focus on mass screening for sickle cell hemoglobinopathy within the Black population.
• Justification for screening includes concerns about potential dangers associated with sickle cell trait.
• The validity of these alleged dangers is disputed.

Purpose of the Study:

• To dispute the alleged dangers of sickle cell trait.
• To highlight the potential social harm of identifying individuals with sickle cell trait.
• To propose alternative strategies for managing sickle cell hemoglobinopathies.

Main Methods:

• Literature review and critical analysis of existing data on sickle cell trait.
• Socio-medical impact assessment of mass screening programs.
• Development of a position statement on the benign nature of sickle cell trait.

Main Results:

• Sickle cell trait is considered benign, with no significant health risks.
• Mass screening and identification can lead to significant social harm for Black individuals.
• Current screening approaches may not be optimally beneficial for sickle cell anemia management.

Conclusions:

• Sickle cell trait should be viewed as a benign condition.
• Focus should shift from mass screening of trait to improving care for sickle cell anemia.
• Avoidance of mandatory patient programs and increased emphasis on research are recommended.